Why the study?
Most reproductive-age women with cardiovascular disease are sexually active, making early counseling on disease-specific contraceptive safety and effectiveness imperative to prevent unplanned pregnancies.
This document provides essential evidence-based recommendations for contraception and reproductive planning in women with cardiovascular disease to prevent unplanned, high-risk pregnancies.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“It is important for cardiovascular clinicians to assess for the need for contraception and appropriateness of contraceptive method both at the time of initial assessment and at subsequent annual encounters in all reproductive age women (age 15-44) with cardiovascular disease. If a patient identified to be at increased risk for pregnancy complications is also noted to be using a contraceptive method with low effectiveness, a discussion of reproductive goals and safe and effective methods of contraception is recommended.”
“While most adolescent and young women with CVD are sexually active, pregnancy and contraception counseling is not routinely discussed with them by their cardiologists. This is an essential part of delivering CV care to this unique patient group. Developing a reproductive plan in conjunction with the patient and her obstetrician can facilitate the use of safe and effective contraception, including the long-acting reversible methods (the IUD and the subdermal implant), thus reducing unintended pregnancies and optimizing maternal and fetal outcomes.”
“Given the significant barriers to and the importance of obtaining safe and effective contraception, ensuring contraceptive access is an important part of providing comprehensive cardiovascular care.”
Clinicians should routinely counsel on CVD-tailored contraception; extends evidence-based guidance to include pregnancy termination.
The majority of reproductive-age women with cardiovascular disease are sexually active. Early and accurate counseling by the cardiovascular team regarding disease-specific contraceptive safety and effectiveness is imperative to preventing unplanned pregnancies in this high-risk group of patients. This document, the final of a 5-part series, provides evidence-based recommendations regarding contraceptive options for women with, or at high risk for, cardiovascular disease as well as recommendations regarding pregnancy termination for women at excessive cardiovascular mortality risk due to pregnancy.
No takes yet. Share an insight, caveat, or question.
Lindley et al. (2021) conducted a review in Cardiovascular disease. Contraceptive options and reproductive planning was evaluated. This document provides evidence-based recommendations regarding contraceptive options and pregnancy termination for women with or at high risk for cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: